What is it about?
This paper reports on currently available diagnostic screening methods for patients infected with SARS-CoV-2 to guide frontline healthcare workers involved with the diagnosis of the 2019 novel coronavirus disease (COVID-19) patient.
Featured Image
Photo by Lucas Vasques on Unsplash
Why is it important?
The recent outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began in Hubei province, China, in December 2019 and has spread worldwide at an alarming rate. With over eight million individuals infected and exceeding 400,000 deaths globally, the necessity to develop fast and efficient diagnostic methods is of high importance.
Perspectives
The preferred diagnostic approach is the reverse transcription (RT) of the virus’ ribonucleic acid (RNA) followed by polymerase chain reaction (PCR) amplification (RT-PCR). However, this method has been proven to be time-consuming. In improving the speed and efficiency of diagnostics, newer rapid diagnostic serological tests are in development for testing SARS-CoV-2, each with its unique advantages and disadvantages.
Dr Adekunle Sanyaolu
Read the Original
This page is a summary of: Navigating the Diagnostics of COVID-19, SN Comprehensive Clinical Medicine, July 2020, Springer Science + Business Media,
DOI: 10.1007/s42399-020-00408-8.
You can read the full text:
Resources
Contributors
The following have contributed to this page
